Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exact Sciences Corporation    EXAS

EXACT SCIENCES CORPORATION

(EXAS)
  Report
Delayed Quote. Delayed Nasdaq - 11/27 01:00:00 pm
118.19 USD   +2.00%
11/27EXACT SCIENCES CORP : Other Events (form 8-K)
AQ
11/10EXACT SCIENCES : Code of Business Conduct and Ethics
PU
11/10EXACT SCIENCES : Policy Governing Director Nominations
PU
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Exact Sciences : SEC Filing - CT ORDER

02/19/2020 | 09:10am EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

February 19, 2020

ORDER GRANTING CONFIDENTIAL TREATMENT

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Exact Sciences Corporation

File No. 0-32179- CF#24927

_____________________

Exact Sciences Corporation submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on March 12, 2010.

Based on representations by Exact Sciences Corporation that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit will not be released to the public for the time period specified:

Exhibit 10.39

through March 12, 2030

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:

Vanessa A. Countryman

Secretary

Disclaimer

EXACT Sciences Corporation published this content on 19 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 February 2020 14:09:07 UTC


© Publicnow 2020
All news about EXACT SCIENCES CORPORATION
11/27EXACT SCIENCES CORP : Other Events (form 8-K)
AQ
11/10EXACT SCIENCES : Code of Business Conduct and Ethics
PU
11/10EXACT SCIENCES : Policy Governing Director Nominations
PU
10/27EXACT SCIENCES : to buy cancer-screening firm Thrive Earlier Detection in $2.15 ..
RE
10/27EXACT SCIENCES : Infographic
PU
10/27EXACT SCIENCES : 3Q Earnings Snapshot
AQ
10/27EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
10/07PFIZER : Will Continue Helping Exact Sciences With Cologuard Promotion Through 2..
DJ
09/21EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
07/31EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
More news
Financials (USD)
Sales 2020 1 451 M - -
Net income 2020 -379 M - -
Net cash 2020 182 M - -
P/E ratio 2020 -48,4x
Yield 2020 -
Capitalization 18 796 M 18 796 M -
EV / Sales 2020 12,8x
EV / Sales 2021 10,2x
Nbr of Employees 4 110
Free-Float 99,1%
Chart EXACT SCIENCES CORPORATION
Duration : Period :
Exact Sciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXACT SCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 150,43 $
Last Close Price 118,19 $
Spread / Highest target 36,2%
Spread / Average Target 27,3%
Spread / Lowest Target 18,5%
EPS Revisions
Managers
NameTitle
Kevin T. Conroy Chairman, President & Chief Executive Officer
Ana Hooker Senior Vice President-Operations
Jeffrey Thomas Elliott Chief Financial Officer
Graham Peter Lidgard Chief Science Officer, SVP-Research & Development
Sandra Statz SVP-Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
EXACT SCIENCES CORPORATION27.80%18 796
WUXI APPTEC CO., LTD.56.53%37 916
IQVIA HOLDINGS INC.9.26%32 365
BEIGENE, LTD.72.47%26 060
HANGZHOU TIGERMED CONSULTING CO.,LTD79.46%15 070
NEUROCRINE BIOSCIENCES, INC.-11.51%8 928